Neuroone Medical Technologies NMTC
NASDAQ NMTC
$1.66 -0.03 (-1.78%)
At close: Sep 9, 2026 · 4:00 PM EDT

Neuroone Medical Technologies (NMTC) Other financing activities (2017 - 2026)

Neuroone Medical Technologies' (NMTC) quarterly Other financing activities came in at -$1.0 in Q1 2026, down 100.0% quarter-over-quarter from $174375.0 in Q4 2025.

Analysis

Neuroone Medical Technologies (NMTC) Other financing activities (2017 - 2026) Analysis & Trends

Neuroone Medical Technologies (NMTC) has reported Other financing activities for 8 consecutive years, with -$1.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to -$1.0; the trailing twelve-month figure through Jun 2026 stood at $2.3 million (changed N/A YoY), and the FY2025 full-year result was $69750.0, down 96.15% from the prior year.
  • Other financing activities fell to -$1.0 in Q1 2026 per NMTC's latest filing, from $174375.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $2.1 million in Q1 2024 and bottomed at -$1.0 in Q1 2026.
  • Historically, Other financing activities has averaged $881210.2 across 4 years, with a median of $715323.0 in 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Neuroone Medical Technologies 14.33 Mn 12.29 Mn 1.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.00
Dec 31, 2025 174,375.00
Mar 31, 2024 2.09 Mn
Dec 31, 2023 1.26 Mn
Jun 30, 2021 62,501.00
Mar 31, 2021 -3.49 Mn
Jun 30, 2020 1,191.00
Sep 30, 2019 84,632.00
Jun 30, 2019 708,551.00
Dec 31, 2017 -440,919.00